Sun, L., Burtness, B., Flamand, Y., Gharzai, L. A., Tang, M., Saba, N. F. (2026). EA3231: A randomized phase III study of BRAF-targeted therapy vs cabozantinib in RAI-refractory differentiated thyroid cancer with
                    <i>BRAF</i>
                    V600Em.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6140